Clinical Trial Update: Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy

View source ↗

Summary

This clinical trial update notes an enrolling-by-invitation study to characterize the effect of dopamine on markers of lymphatic circulation in Fontan-associate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Fontan-associated Protein-losing Enteropathy
• Protein-losing Enteropathy
• Single-ventricle Congenital Heart Disease

Drugs mentioned

• Dopamine (dopamine)

Snippet

Sponsor: University of Michigan | Conditions: Dopamine, Protein-Losing Enteropathies | Status: ENROLLING_BY_INVITATION